Showing results (351-360 of 824) with videos related to

Sort By:
Pageof 83
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple MyelomaGüllü Görgün, Mehmet K Samur, Kristen B Cowens, et al.
Cancers|June 11, 2020
BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple MyelomaShih-Feng Cho, Liang Lin, Lijie Xing, et al.
Seminars in Oncology|October 19, 2013
Decoding the pathophysiology and the genetics of multiple myeloma to identify new therapeutic targetsPanisinee Lawasut, Richard W J Groen, Eugen Dhimolea, et al.
Expert Opinion on Pharmacotherapy|November 28, 2017
Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and againstPaul G Richardson, Sarah A Holstein, Robert L Schlossman, et al.
Leukemia|April 3, 2020
Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathwaysTeru Hideshima, Daisuke Ogiya, Jiye Liu, et al.
Antibodies (Basel, Switzerland)|September 25, 2019
Monoclonal Antibody: A New Treatment Strategy against Multiple MyelomaShih-Feng Cho, Liang Lin, Lijie Xing, et al.
Blood Cancer Journal|December 10, 2023
BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myelomaDebasmita Dutta, Jiye Liu, Kenneth Wen, et al.
British Journal of Haematology|April 27, 2012
A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myelomaJooeun Bae, Weihua Song, Robert Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2012
Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disordersJooeun Bae, Robert Smith, John Daley, et al.
Antioxidants & Redox Signaling|February 17, 2024
DAMPening Tumor Immune Escape: The Role of Endoplasmic Reticulum Chaperones in Immunogenic ChemotherapySelma Cifric, Marcello Turi, Pietro Folino, et al.
Pageof 83